The Relationship Between Maternal Glycemia and Perinatal Outcome
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the relationship between varying degrees of maternal hyperglycemia and pregnancy outcomes. METHODS: This was a secondary analysis of a treatment trial for mild gestational diabetes including four cohorts: 1) 473 women with untreated mild gestational diabetes; 2) 256 women with a positive 50-g screen and one abnormal oral glucose tolerance test (OGTT) value; 3) 675 women with a positive screen and no abnormal OGTT values; and 4) 437 women with a normal 50-g screen. Groups were compared by test of trend for a composite perinatal outcome (neonatal hypoglycemia, hyperbilirubinemia, elevated cord C-peptide level, and perinatal trauma or death), frequency of large for gestational age neonates, shoulder dystocia, and pregnancy-related hypertension. Three-hour OGTT levels (fasting, 1-, 2-, and 3-hour) levels were divided into categories and analyzed for their relationship to perinatal and maternal outcomes. RESULTS: There were significant trends by glycemic status among the four cohorts for the composite and all other outcomes (P<.001). Analysis for trend according to OGTT categories showed an increasing relationship between fasting and all postload levels and the various outcomes (P<.05). Fasting glucose 90 mg/dL or greater and 1 hour 165 mg/dL or greater were associated with an increased risk for the composite outcome (odds ratios and 95% confidence intervals of 2.0 [1.03–4.15] and 1.46 [1.02–2.11] to 1.52 [1.08–2.15] for the fasting and 1 hour, respectively). A 1 hour glucose 150 mg/dL or greater was associated with an increased risk for large for gestational age (odds ratios, 1.8 [1.02–3.18] to 2.35 [1.35–4.14]); however, 2- and 3-hour glucose levels did not increase the risk for the composite or large for gestational age until well beyond current gestational diabetes diagnostic thresholds. CONCLUSION: A monotonic relationship exists between increasing maternal glycemia and perinatal morbidity. Current OGTT criteria require reevaluation in determining thresholds for the diagnosis and treatment of gestational diabetes. LEVEL OF EVIDENCE: II
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Perinatal outcomes are linked to maternal glycemia in a continuous fashion; no distinct threshold exists above which the risk of adverse outcomes dramatically increases as compared to below.(1-3)”
From Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes (2016) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“Percentage of infants with LGA by OGTT Glucose Level Fasting OGTT (mg/dL): (1) < 75, (2) 75-79, (3) 80-84, (4) 85-89, (5) 90-94 1 Hour OGTT (mg/dL): (1) < 150, (2) 150-164, (3) 165-179, (4) 180-194, (5) ≥ 195 2 Hour OGTT (mg/dL): (1) <125, (2) 125-139, (3) 140-154, (4) 155-169, (5) ≥ 170 3 Hour OGTT (mg/dL): (1) < 110…”
Self-citationCriteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
Self-citationMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Sermer, M., Naylor, C. D., Gare, D. J., Kenshole, A. B., Ritchie, J. W. K., Farine, D., Cohen, H. R., McArthur, K., Holzapfel, S., Biringer, A., et al. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90183-3 · Cited by 510
Screening criteria for high-risk gestational diabetic patients
O'Sullivan, J. B., Mahan, C. M., Charles, D., & Dandrow, R. V. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33833-9 · Cited by 478
Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy
Sacks, D. A., Greenspoon, J. S., Abu-Fadil, S., Henry, H. M., Wolde-Tsadik, G., & Yao, J. F. F. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90580-4 · Cited by 210
Research works printed but not linked: 1
- Categorical Data Analysis 1st Agresti Alan New York Wiley 1990 0-471-85301-1 100 102
Cited by
The Hyperglycemia and Adverse Pregnancy Outcome Study
Catalano, P. M., McIntyre, H. D., Cruickshank, J. K., McCance, D. R., Dyer, A. R., Metzger, B. E., Lowe, L. P., Trimble, E. R., Coustan, D. R., Hadden, D. R., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1790 · Cited by 954
Self-citationKoivusalo, S. B., Rönö, K., Klemetti, M. M., Roine, R. P., Lindström, J., Erkkola, M., Kaaja, R. J., Pöyhönen-Alho, M., Tiitinen, A., Huvinen, E., et al. (2016) · Diabetes Care · doi:10.2337/dc15-0511 · Cited by 436
Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis
Farrar, D., Simmonds, M., Bryant, M., Sheldon, T. A., Tuffnell, D., Golder, S., Dunne, F., & Lawlor, D. A. (2016) · BMJ · doi:10.1136/bmj.i4694 · Cited by 413
Genetic evidence for causal relationships between maternal obesity-related traits and birth weight
Tyrrell, J., Richmond, R. C., Palmer, T. M., Feenstra, B., Rangarajan, J., Metrustry, S., Cavadino, A., Paternoster, L., Armstrong, L. L., De Silva, N. M. G., et al. (2016) · JAMA · doi:10.1001/jama.2016.1975 · Cited by 284
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Vigod, S. N., Gomes, T., Wilton, A. S., Taylor, V. H., & Ray, J. G. (2015) · BMJ · doi:10.1136/bmj.h2298 · Cited by 162
Farrar, D., Simmonds, M., Griffin, S., Duarte, A., Lawlor, D. A., Sculpher, M., Fairley, L., Golder, S., Tuffnell, D., Bland, M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20860 · Cited by 117
“> 6 mmol/l at 2 hours post load), although this observation is driven primarily by one study.(61) Association between 1-mmol/l increases in fasting and post-load glucose levels and risk of adverse perinatal outcomes This section examines the trends in adverse perinatal outcomes (see Appendix 2, Figures 52–60) and incr…”
BackgroundMethodRETIRED: Diabetes in Pregnancy
Berger, H., Gagnon, R., & Sermer, M. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.04.002 · Cited by 108
Guideline No. 393-Diabetes in Pregnancy
Berger, H., Gagnon, R., & Sermer, M. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.03.008 · Cited by 106
Roeckner, J. T., Sanchez‐Ramos, L., Knupp, R. J., & Kaunitz, A. M. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.04.040 · Cited by 109
The Empirical Evidence for the Telemedicine Intervention in Diabetes Management
Bashshur, R. L., Shannon, G. W., Smith, B. R., & Woodward, M. A. (2015) · Telemedicine and e-Health · doi:10.1089/tmj.2015.0029 · Cited by 102
Jamilian, M., Amirani, E., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.10.028 · Cited by 97
“Insulin dysfunction occurs in GDMmight both progress to T2DM in later life and leads to neonatal complications [31].”
RetractedThe influence of maternal BMI and gestational diabetes on pregnancy outcome
Martin, K. E., Grivell, R. M., Yelland, L. N., & Dodd, J. M. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.12.015 · Cited by 106
“[29] Landon MB, Mele L, Spong CY, Carpenter MW, Ramin SM, Casey B, et al.”
BackgroundJamilian, M., Samimi, M., Ebrahimi, F. A., Hashemi, T., Taghizadeh, M., Razavi, M., Sanami, M., & Asemi, Z. (2017) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.01.011 · Cited by 96
Ethridge, J. K., Catalano, P. M., & Waters, T. P. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000412 · Cited by 95
“This approach was taken as data support that women with a normal 50-g glucose screen may not have similar pregnancy outcomes compared with women with a positive screen, but normal 3hour OGTT results.(8) The IADPSG criteria were established using the original Hyperglycemia and Adverse Pregnancy Outcomes trial data, in…”
MethodSelf-citationHod, M., Kapur, A., & McIntyre, H. D. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.01.206 · Cited by 81
Rönö, K., Stach-Lempinen, B., Klemetti, M. M., Kaaja, R. J., Pöyhönen-Alho, M., Eriksson, J. G., & Koivusalo, S. B. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-70 · Cited by 80
Fong, A., Serra, A., Herrero, T., Pan, D., & Ogunyemi, D. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.08.009 · Cited by 75
“The Hyperglycemia and Adverse Pregnancy Outcomes study by Landon demonstrated a linear relationship between maternal glucose levels and adverse pregnancy outcome (Metzger et al., 2008; Landon et al., 2011).”
BackgroundChong, Y.-S., Cai, S., Lin, H., Soh, S. E., Lee, Y.-S., Leow, M. K.-S., Chan, Y.-H., Chen, L., Holbrook, J. D., Tan, K.-H., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-345 · Cited by 74
“Beneficial effects have been reported on both maternal and fetal outcomes with detection and treatment of even mild GDM [40-45].”
BackgroundNguyen, B. T., Cheng, Y. W., Snowden, J. M., Esakoff, T. F., Frias, A. E., & Caughey, A. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.049 · Cited by 70
“mia,(6) shoulder dystocia,(7) neonatal jaunice,(8) and neonatal hypoglycemia.(9) The incidence of GDM has increased dramatically in the past decade in all racial/ ethnic groups.”
Geurtsen, M. L., van Soest, E. E. L., Voerman, E., Steegers, E. A. P., Jaddoe, V. W. V., & Gaillard, R. (2019) · Diabetologia · doi:10.1007/s00125-019-4957-3 · Cited by 80
Maternal BMI, glucose tolerance, and adverse pregnancy outcomes
Stuebe, A. M., Landon, M. B., Lai, Y., Spong, C. Y., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.04.035 · Cited by 70
Self-citationYoung, B. C., & Ecker, J. L. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0338-8 · Cited by 81
Diagnosis of GDM: A suggested consensus
McIntyre, D. H., Colagiuri, S., Roglić, G., & Hod, M. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.04.022 · Cited by 77
Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L. (2014) · Diabetic Medicine · doi:10.1111/dme.12357 · Cited by 66
Schmidt, C., Voorhorst, I., van de Gaar, V. H. W., Keukens, A., van Loon, B. J. P., Snoek, F. J., & Honig, A. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2376-6 · Cited by 67
Feng, H., Zhu, W., Yang, H.-X., Wei, Y.-M., Wang, C., Su, R., Hod, M., & Hadar, E. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.204928 · Cited by 60
“In addition, it is unclear whether fasting or postload glucose values are more closely related to adverse perinatal outcomes and whether they represent different or specific risks.[4,6,7]”
BackgroundHarper, L. M., Mele, L., Landon, M. B., Carpenter, M. W., Ramin, S. M., Reddy, U. M., Casey, B., Wapner, R. J., Varner, M. W., Thorp, J. M., et al. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001383 · Cited by 56
Self-citationYu, L., Zeng, X., Cheng, M., Yang, G.-Z., Wang, B., Xiao, Z., Luo, X., Zhang, B., Xiao, D.-W., Zhang, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17824 · Cited by 52
Rönö, K., Stach‐Lempinen, B., Eriksson, J. G., Pöyhönen‐Alho, M., Klemetti, M. M., Roine, R. P., Huvinen, E., Andersson, S., Laivuori, H. M., Valkama, A., et al. (2018) · International Journal of Women s Health · doi:10.2147/ijwh.s162061 · Cited by 53
“34 respiratory distress or transient tachypnea of newborn 3 (5) 4 (8) 0.”
Diabetes and the Female Reproductive System
Nandi, A. A., & Poretsky, L. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.007 · Cited by 55
Diagnosing gestational diabetes: can expert opinions replace scientific evidence?
Long, H. (2011) · Diabetologia · doi:10.1007/s00125-011-2228-z · Cited by 56
“The MFMU study randomised women with at least two post-100 g load abnormal glucose values and although a secondary analysis found similar frequencies of adverse outcomes among nonrandomised untreated women with only one abnormal OGTT value [13], one cannot validly infer treatment benefits to them.”
Plasma glycated CD59, a novel biomarker for detection of pregnancy-induced glucose intolerance
Ghosh, P., Luque-Fernandez, M. A., Vaidya, A., Ma, D., Sahoo, R., Chorev, M., Zera, C., McElrath, T. F., Williams, M. A., Seely, E. W., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2598 · Cited by 48
“…glucose challenge methods currently used to screen/diagnose GDM. Glucose challenge tests fail to recognize the continuous association between maternal hyperglycemia and abnormal pregnancy outcomes, and exclude milder forms of glucose intolerance that may still impart perinatal risk (16; 17).”
Liao, S., Liu, Y., Tan, Y.-D., Gan, L., Mei, J., Song, W., Shu, C., Dong, X., Chen, X., & Deng, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040113 · Cited by 48
“Recent studies reported that adverse maternal-fetal outcomes were observed across the spectrum of carbohydrate intolerance including glucose values below current cutoffs for the diagnosis of GDM [2,3].”
BackgroundMild Gestational Diabetes and Adverse Pregnancy Outcome: A Systemic Review and Meta-Analysis
Yarandi, R. B., Vaismoradi, M., Panahi, M. H., Kymre, I. G., & Behboudi‐Gandevani, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.699412 · Cited by 57
WISP1 is a novel adipokine linked to metabolic parameters in gestational diabetes mellitus
Sahin Ersoy, G., Altun Ensari, T., Subas, S., Giray, B., Simsek, E. E., & Cevik, O. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1192118 · Cited by 45
“The prevalence of GDM ranges from 5% to 20% among different populations and according to different screening strategies [3,4].”
BackgroundFlash glucose monitoring in gestational diabetes mellitus (FLAMINGO): a randomised controlled trial
Majewska, A., Stanirowski, P. J., Tatur, J., Wojda, B. K., Radosz, I., Wielgoś, M., & Bomba-Opon, D. A. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02091-2 · Cited by 51
“It is believed, that adverse perinatal outcomes correlate proportionally to the level of maternal dysglycaemia [2, 4, 5].”
BackgroundPrediction of gestational diabetes mellitus at first trimester in low-risk pregnancies
Kumru, P., Arisoy, R., Erdogdu, E., Demirci, O., Kavrut, M., Ardıc, C., Aslaner, N., Ozkoral, A., & Ertekin, A. (2016) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2016.04.032 · Cited by 41
“Published b Several studies have demonstrated the relationship between GDM and adverse short- and long-term maternalefetal outcomes [4,5].”
BackgroundThe diagnostic criteria for gestational diabetes: to change or not to change?
Reece, E. A., & Moore, T. R. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.887 · Cited by 48
“There is growing evidence that elevated plasma glucose concentrations, or hyperglycemia, below what is currently considered GDM are pathologic to fetuses.(6) Thus, many clinicians have called for adopting a more aggressive approach The different screening and diagnostic me currently in clinical use have led the Natio…”
BackgroundChon, S. J., Kim, S. Y., Cho, N. R., Min, D. L., Hwang, Y. J., & Mamura, M. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.2.352 · Cited by 43
Persson, M., Fadl, H., Hanson, U., & Pasupathy, D. (2013) · Diabetes Care · doi:10.2337/dc13-0899 · Cited by 43
Overweight and obesity: a remaining problem in women treated for severe gestational diabetes
Hildén, K., Hanson, U., Persson, M., & Fadl, H. (2016) · Diabetic Medicine · doi:10.1111/dme.13156 · Cited by 34
Chen, L., Wang, W.-J., Auger, N., Xiao, L., Torrie, J., McHugh, N. G.-L., & Luo, Z.-C. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025084 · Cited by 30
Gestational diabetes and macrosomia by race/ethnicity in Hawaii
Tsai, P.-J. S., Roberson, E., & Dye, T. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-395 · Cited by 30
“; licensee BioMed Central Ltd Commons Attribution License (http://creativec reproduction in any medium, provided the or neonatal hyperbilrubinemia [4].”
BackgroundSon, K. H., Lim, N.-K., Lee, J. ‐., Cho, M. ‐., & Park, H. (2014) · Diabetic Medicine · doi:10.1111/dme.12656 · Cited by 30
The proposed GDM diagnostic criteria: a difference, to be a difference, must make a difference
Langer, O., Umans, J. G., & Miodovnik, M. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.734874 · Cited by 31
Maternal and Perinatal Outcomes in Women with Insulin Resistance
Tuuli, M. G., Stout, M. J., Macones, G. A., Cahill, A. G., & Temming, L. A. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1572434 · Cited by 28
Öztürk, F. Y., & Altuntaş, Y. (2015) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.5350/semb.20150317014238 · Cited by 36
Villarroel, C., Salinas, A., López, P. V., Kohen, P., Rencoret, G., Devoto, L., & Ethel Codner, D. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1248933 · Cited by 29
“pregestational and GD during pregnancy are at higher risk of developing chronic diseases during childhood and adolescence, such as obesity, hypertension and metabolic syndrome [29,30].”
BackgroundBernardo, S. D., Mivelaz, Y., Epure, A. M., Vial, Y., Siméoni, U., Bovet, P., Younes, S. E., Chioléro, A., & Sekarski, N. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016972 · Cited by 29
Sagedal, L. R., Vistad, I., Øverby, N. C., Bere, E. T., Torstveit, M. K., Lohne‐Seiler, H., Hillesund, E. R., Pripp, A. H., & Henriksen, T. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1340-6 · Cited by 26
“Observational studies demonstrate a linear relationship between maternal glucose levels and adverse obstetrical outcomes, particularly fetal macrosomia [1, 2], and randomized trials demonstrate that treatment of mild hyperglycemia reduces the incidence of these same outcomes [3, 4].”
BackgroundMaternal diet and gestational diabetes mellitus development
Mizgier, M., Jarząbek‐Bielecka, G., & Mruczyk, K. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1598364 · Cited by 31
The relationship of maternal glycemia to childhood obesity and metabolic dysfunction‡
Landon, M. B., Mele, L., Varner, M. W., Casey, B. M., Reddy, U. M., Wapner, R. J., Rouse, D. J., Tita, A., Thorp, J. M., Chien, E. K., et al. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1484094 · Cited by 29
Self-citationThe Relationship Between Maternal Glycemia and Perinatal Outcome
Greenberg, J. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182176774 · Cited by 27
Huvinen, E., Grotenfelt, N. E., Eriksson, J. G., Rönö, K., Klemetti, M. M., Roine, R. P., Pöyhönen‐Alho, M., Tiitinen, A. E., Andersson, S., Laivuori, H. M., et al. (2016) · Annals of Medicine · doi:10.3109/07853890.2015.1131328 · Cited by 26
“The documentation of unfavorable consequences of GDM and overweight is solid, showing long-term health consequences for both the mother and the offspring (4,6,7) and forming a great incentive to search for efficient GDM”
BackgroundDaly, N., Carroll, C., Flynn, I., Harley, R., Maguire, P., & Turner, M. J. (2016) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14255 · Cited by 28
Can Obstetric Risk Factors Predict Fetal Acidaemia at Birth? A Retrospective Case-Control Study
Kapaya, H., Williams, R., Elton, G., & Anumba, D. O. C. (2018) · Journal of Pregnancy · doi:10.1155/2018/2195965 · Cited by 22
Daly, N., Stapleton, M., O’Kelly, R., Kinsley, B., Daly, S., & Turner, M. J. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.03.022 · Cited by 22
Relation of maternal vitamin D status with gestational diabetes mellitus and perinatal outcome
Mutlu, N., Esra, H., Begum, A., Fatma, D., Arzu, Y., Yalçın, H. R., Fatih, K., & Selahattin, K. (2015) · African Health Sciences · doi:10.4314/ahs.v15i2.27 · Cited by 28
The impact of diabetes mellitus on the course and outcome of pregnancy during a 5-year follow-up
Mitrović, M., Stojic, S., Tešić, D., Popovic, D. S., Rankov, O., Tomić-Naglić, D., Novaković-Paro, J., Pejin, R., Bulatovic, S., Todorovic-Veljic, M., et al. (2014) · Vojnosanitetski pregled · doi:10.2298/vsp1410907m · Cited by 19
Comparative effectiveness of metformin versus insulin for gestational diabetes in New Zealand
Landi, S. N., Radke, S., Boggess, K., Engel, S. M., Stürmer, T., Howe, A. S., & Funk, M. J. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4907 · Cited by 21
Ying, Q., Xu, Y., Zhang, Z., Cai, L., Zhao, Y. M., & Jin, L. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02131-3 · Cited by 20
“GDM can have an impact on perinatal outcomes, including a higher incidence of preterm birth, neonatal hypoglycemia, mac-rosomia, maternal and neonatal birth injuries [19–23].”
BackgroundCissé, O., Fajardy, I., Dickès-Coopman, A., Moitrot, E., Montel, V., DELOOF, S., Rousseaux, J., Vieau, D., & Laborie, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064251 · Cited by 19
“[7,8].”
Diagnosing Gestational Diabetes Mellitus: Rationed or Rationally Related to Risk?
McIntyre, D. H. (2013) · Diabetes Care · doi:10.2337/dc13-1250 · Cited by 22
Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes
Cade, W. T., Tinius, R. A., Reeds, D. N., Patterson, B. W., & Cahill, A. G. (2016) · Diabetes · doi:10.2337/db15-1061 · Cited by 18
Oostdam, A. S. H.-V., Salgado‐Bustamante, M., López, J. A., Oostdam, D. A. H.-V., & López‐Hernández, Y. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0468 · Cited by 18
Rottenstreich, M., Rotem, R., Reichman, O., Farkash, R., Rottenstreich, A., Samueloff, A., & Sela, H. Y. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108364 · Cited by 20
Assaf-Balut, C., Familiar, C., de la Torre, N. G., Rubio, M. Á., Bordiú, E., del Valle, L., Lara, M., Ruiz, T., Ortolá, A., Crespo, I., et al. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000314 · Cited by 19
“2 3 Considering that both EW and GDM coexist frequently because of their shared physiopathological characteristics derived from insulin resistance, it becomes rather challenging to determine the speci fi c effects on maternal and neonatal outcomes of each one independently.”
BackgroundHokkanen, L., Launes, J., & Michelsson, K. (2013) · F1000Research · doi:10.12688/f1000research.2-50.v1 · Cited by 20
Comparison of Birth Outcomes by Gestational Diabetes Screening Criteria
Davis, E. M., Scifres, C., Abebe, K. Z., Costacou, T., COMER, D. M., Catalano, P. M., Simhan, H. N., Freiberg, M. S., & Day, N. L. (2018) · American Journal of Perinatology Reports · doi:10.1055/s-0038-1675343 · Cited by 18
Self-citationThe impact of new national guidelines on screening for gestational diabetes mellitus.
Ali, F., Farah, N., O’Dwyer, V., O’Connor, C., Kennelly, M., & Turner, M. J. (2013) · PubMed · Cited by 16
Jeffery, T., Petersen, R. W., & Quinlivan, J. A. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12487 · Cited by 15
Research progress of metformin in gestational diabetes mellitus: a narrative review
Ouyang, H., Al-Mureish, A., & Wu, N. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-192 · Cited by 19
“Blood glucose control during pregnancy depends mostly on a combination of health interventions, medications and blood glucose selfmonitoring (7).”
BackgroundGlucose intolerance in the third trimester is not predictive of adverse outcomes
Fonseca, A., Lopes, J. M., & Clode, N. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12923 · Cited by 16
Hirsch, A., Peled, T., Schlesinger, S., Sela, H. Y., Grisaru‐Granovsky, S., & Rottenstreich, M. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07587-y · Cited by 17
“Typically, the hyperglycemic state associated with GDM results in fetal hyperinsulinemia, leading to the development of large for gestational age (LGA) infants with specific associated morbidity [3, 4].”
BackgroundManagement of diabetes and pregnancy – When to start and what pharmacological agent to choose?
Hiersch, L., & Yogev, Y. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.04.020 · Cited by 16
Nicolosi, B. F., Vernini, J. M., Costa, R., Magalhães, C. G., Rudge, M. V. C., Corrente, J. E., Cecatti, J. G., & Calderon, I. D. M. P. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00556-w · Cited by 20
Edwards, K. J., Maslin, K., Andrade, J., Jones, R. B., & Shawe, J. (2022) · JBI Evidence Synthesis · doi:10.11124/jbies-21-00294 · Cited by 15
Roeckner, J. T., Bennett, S. N., Mitta, M., Sanchez‐Ramos, L., & Kaunitz, A. M. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1706473 · Cited by 13
What we have learned about treating mild gestational diabetes mellitus
Rice, M. M., & Landon, M. B. (2016) · Seminars in Perinatology · doi:10.1053/j.semperi.2016.03.006 · Cited by 14
Self-citationMarch, M. I., Modest, A. M., Ralston, S. J., Hacker, M. R., Gupta, M., & Brown, F. M. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1038513 · Cited by 12
“A number of studies have demonstrated that increasing levels of carbohydrate intolerance, even in women who were not diagnosed with GDM by customary criteria, have been associated with increased frequency of maternal– fetal complications [7–12].”
BackgroundWang, P., Lu, M., & Yan, Y. (2013) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2013.10.005 · Cited by 13
“However, there were no apparent thresholds at which the risks were found to increase [8,18,19].”
BackgroundUmbilical cord blood concentration of connecting peptide (C-peptide) and pregnancy outcomes
Niknam, A., Tehrani, F. R., Behboudi‐Gandevani, S., Rahmati, M., Hedayati, M., Abedini, M., Firouzi, F., Torkestani, F., Zokaee, M., & Azizi, F. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-05081-4 · Cited by 12
Gestational Diabetes Mellitus Update and Review of Literature
Cheung, K. W., & Wong, S.-N. (2018) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.s2-008 · Cited by 14
“Hyperglycaemia during pregnancy is found to be associated with various maternal and perinatal adverse outcomes [2,3].”
BackgroundKariniemi, K., Vääräsmäki, M., Männistö, T. I., Mustaniemi, S., Kajantie, E., Eteläinen, S., Keikkala, E., the Finnish Gestational Diabetes [FinnGeDi] study group, Pouta, A. M., Kaaja, R., et al. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06473-4 · Cited by 9
Parrettini, S., Ranucci, L., Caroli, A., Bini, V., Calafiore, R., & Torlone, E. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.08.002 · Cited by 11
The Effectiveness of D-Chiro Inositol Treatment in Gestational Diabetes
Biase, N. D., Martinelli, M., Florio, V., Meldolesi, C., & Bonito, M. (2017) · Diabetes Case Reports · doi:10.4172/2572-5629.1000131 · Cited by 11
“Incidence of GDM varies from 2% to 14% worldwide and is growing [2] and hyperglycaemia has been independently associated with a risk for mother, foetus and neonate, both in the short and long term [3,4].”
BackgroundEndocrine Diseases of Pregnancy
Edlow, A. G., & Norwitz, E. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00027-5 · Cited by 10
Gestational diabetes needs to be managed
McIntyre, D. H., & Oats, J. J. N. (2013) · The Medical Journal of Australia · doi:10.5694/mja12.11368 · Cited by 8
Fainstein, N., Herman, H. G., Gluck, O., Schreiber, L., & Kovo, M. (2022) · Placenta · doi:10.1016/j.placenta.2022.02.009 · Cited by 8
Zhang, E., Su, S., Gao, S., Zhang, Y., Liu, J., Xie, S., Yue, W., Liu, R., & Yin, C. (2023) · Annals of Medicine · doi:10.1080/07853890.2024.2302516 · Cited by 8
“…the hG pattern but higher than those in the lG pattern, while the risk of late-onset GDM in the MG pattern had the same trend. this is similar to the study conducted by landon et al., which showed a significant relationship between increased maternal glycaemia and adverse pregnancy outcomes [24].”
ResultMoll, U., Olsson, H. L., & Landin‐Olsson, M. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-2741-5 · Cited by 9
“It is well known that gestational diabetes (GDM) can result in diabetic fetopathy with an increased risk for caesarean section and postnatal complications [13, 14].”
BackgroundJenum, A. K., Richardsen, K. R., Berntsen, S., & Mørkrid, K. (2013) · Norsk Epidemiologi · doi:10.5324/nje.v23i1.1602 · Cited by 10
“Although positive short-time effects are observed (52,53), only a marginal effect on the prevalence of macrosomia can be expected (50).”
BackgroundEdwards, K. J., Maslin, K., Andrade, J., Jones, R. B., & Shawe, J. (2020) · JBI Evidence Synthesis · doi:10.11124/jbies-20-00151 · Cited by 8
Reif, P., Panzitt, T., Moser, F., Resch, B., Haas, J. G., & Lang, U. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.789845 · Cited by 7
Outcome‐based diagnosis of hyperglycemia in pregnancy in Kinshasa, Democratic Republic of Congo
Tandu‐Umba, B., & Muela, A. M. (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.08.010 · Cited by 6
“Thus, the declining frequencies of outcomes observed beyond 105 mg/dL strongly suggest a clinical improvement of maternal/perinatal conditions reflecting glycemic loweringmanagement, which is in accordance with the benefits of treating nondiabetic hyperglycemia during pregnancy as reported by other clinicians [3].”
ResultMulla, W. R. (2016) · Diabetes Spectrum · doi:10.2337/diaspect.29.2.89 · Cited by 7
“(7,8) showed that treating mild GDM with diet, self-monitoring of blood glucose, and insulin therapy to reduce hyperglycemia and prevent postprandial hyperglycemia significantly decreased the risk of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders.”
BackgroundOrdoñez, J. S. F., Pérez-Gualdrón, C. E., & Saavedra-Ortega, D. R. (2016) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v64n4.54569 · Cited by 18
“…los puntos de corte de la PTOG durante el periodo gestacional como criterios diagnósticos a tener en cuenta para DMG. Más adelante, algunos reportes documentaron el aumento de resultados adversos maternofetales con la elevación de solo un valor de las glicemias medidas en la PTOG (24,25).”
BackgroundMaternal and perinatal risk factors for neonatal morbidity: a narrative literature review
Núñez, J. H., Yong, M. V., Vázquez, Y. D. L. C. S., & Quintana, M. D. L. C. L. (2015) · Medwave · doi:10.5867/medwave.2015.06.6182 · Cited by 6
Wang, H., Yin, W., Ma, S., Wang, P., Zhang, L., Chen, X., & Zhu, P. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101183 · Cited by 5
Metadata
- Authors
- Landon, M. B., Mele, L., Spong, C. Y., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., Sciscione, A., Catalano, P., Harper, M., Saade, G., Caritis, S. N., Sorokin, Y., Peaceman, A. M., Tolosa, J. E., & Anderson, G. D.
- Affiliations
- University of Pittsburgh (US)
- University of Utah (US)
- ORCID
- Venue
- Obstetrics & Gynecology
- Published
- 2011-02
- Volume
- 117
- Issue
- 2
- Pages
- 218-224
- ISSN
- 0029-7844 (ISSN-L)
- PMC
- PMC3979319
- OpenAlex
- W2136548094
- Cited by
- 150
- References
- 17
- Citations by year
- 2025: 4 · 2024: 9 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 15 · 2018: 8 · 2017: 9 · 2016: 21 · 2015: 11 · 2014: 11 · 2013: 20 · 2012: 12
- FWCI
- 19.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (2r24hd050924-06)
- National Center for Research Resources (C06RR011234, M01RR000080, M01-RR-00034, UL1RR024989, UL1RR025764, M01RR00080, M01RR000034)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD40512, HD53118, U01HD036801, R24 HD-050924, HD27917, U10HD040544, U10HD034208, HD-27915, U10HD040512, HD34116, UG1HD034116, HD40545, HD34136, (HD40500, UG1HD053097, U10HD027915, U10HD040545, U10HD040560, HD 40544, HD-27860, HD40560, HD53097, U10HD027917, U10HD036801, U10HD027860, U10HD021410, HD 34208, HD 36801, U10HD053097, U10HD034116, HD27869, [HD21410, U10HD040500, U10HD040485, U10HD053118, U10HD027869, U10HD034136, UG1HD034208, U24HD036801, UG1HD040500, UG1HD040512, UG1HD027869, UG1HD040544, UG1HD040485, UG1HD027915, UG1HD040560, UG1HD040545, HD 40485)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Keywords
- maternal hyperglycemia, gestational diabetes mellitus, perinatal outcomes, oral glucose tolerance test, fasting blood glucose, large for gestational age, neonatal hypoglycemia, hyperbilirubinemia, shoulder dystocia, pregnancy-related hypertension, perinatal morbidity, neonatal death, perinatal trauma
- MeSH terms
- Adult, Blood Glucose, Female, Glucose Tolerance Test, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, United States, Logistic Models, Randomized Controlled Trials as Topic, Diabetes, Gestational, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.